One Year After the Supreme Court's MedImmune Decision: Preemptive Patent Lawsuits Resurgent?

摘要

Due to the Supreme Court's rejection of the reasonable apprehension test, uncertainty and inefficiency abounds in the area of patent notification and license negotiations. In the coming months and years, the courts will hopefully provide further guidance